Phase II trial of cabozantinib (cabo) plus durvalumab (durva) in chemotherapy refractory microsatellite stable (MSS) patients with advanced gastric and esophageal (G/E) adenocarcinoma: CAMILLA G/E cohort results.
| Autor: | Saeed, Anwaar, Park, Robin, Dai, Junqiang, Kasi, Anup, Barbosa, Lori, Mulvaney, Kelly, Rarden, Jordan, Phadnis, Milind A., Saeed, Azhar, Sahin, Ibrahim Halil, Baranda, Joaquina Celebre, Williamson, Stephen K., Sun, Weijing, Al-Rajabi, Raed Moh'd Taiseer |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p373-373, 185p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|